BOSTON SCIENTIFIC CORPORATION

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

CoverEdge Algorithm Programming Study

Not Applicable
Completed
Conditions
First Posted Date
2015-07-09
Last Posted Date
2022-11-04
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
15
Registration Number
NCT02492880
Locations
🇺🇸

Albany Medical Center, Albany, New York, United States

🇺🇸

Barolat Neuroscience, Denver, Colorado, United States

Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement (REPRISE Japan)

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2015-07-08
Last Posted Date
2021-09-28
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
70
Registration Number
NCT02491255
Locations
🇯🇵

Osaka University Hospital, Suita, Osaka, Japan

🇯🇵

Shonankamakura General Hospital, Kamakura, Kanagawa, Japan

🇯🇵

Kurashiki Central Hospital, Kurashiki, Okayama, Japan

and more 2 locations

Optimizing Pacing Therapy by Using Multi-Programmable Pulse Generators for Cardiac Resynchronization Pacing (CRT-P)

First Posted Date
2015-07-02
Last Posted Date
2019-09-20
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
64
Registration Number
NCT02488239
Locations
🇩🇪

Herz-und Gefäßzentrum Göttingen, Göttingen, Germany

🇩🇪

Unfallkrankenhaus Berlin, Berlin, Germany

🇩🇪

Krankenhaus Landshut-Achdorf, Landshut, Germany

and more 5 locations

The Captivator EMR Registry

Completed
Conditions
First Posted Date
2015-06-26
Last Posted Date
2018-03-07
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
291
Registration Number
NCT02482701
Locations
🇳🇱

Erasmus MC - University Medical Center, Rotterdam, Netherlands

🇬🇧

Addenbrookes Hospital, Cambridge, Cambridgeshire, United Kingdom

🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

and more 9 locations

Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2015-06-25
Last Posted Date
2021-04-21
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
5
Registration Number
NCT02481960
Locations
🇫🇷

Centre Hopsitalier Universitaire d'Angers, Angers, France

🇩🇪

Prof. Erol Sandalcioglu, Hannover, Germany

FAST Feasibility Study

First Posted Date
2015-06-12
Last Posted Date
2022-06-22
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
33
Registration Number
NCT02470884
Locations
🇦🇺

The Prince Charles Hospital, Chermside, Queensland, Australia

🇦🇺

Peninsula Health, Frankston, Victoria, Australia

🇦🇺

Monash Medical Centre, Melbourne, Victoria, Australia

and more 4 locations

COMFORT: A Multicenter, Open-label, Randomized, Crossover Study

First Posted Date
2015-06-04
Last Posted Date
2021-04-21
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
35
Registration Number
NCT02462720
Locations
🇺🇸

Venous Institute of Buffalo, Amherst, New York, United States

🇺🇸

Lake Washington Vascular, Bellevue, Washington, United States

🇺🇸

Coastal Vascular and Interventional, PLLC, Pensacola, Florida, United States

and more 1 locations

A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma

First Posted Date
2015-06-03
Last Posted Date
2021-02-12
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
2
Registration Number
NCT02460991
Locations
🇺🇸

University of Alabama Hospital, Birmingham, Alabama, United States

🇺🇸

University of Southern California, Los Angeles, California, United States

🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

and more 3 locations

Study of Intraparenchymal Therapy as Adjunct Therapy in Patients With Recurrent, Resectable Glioblastoma Multiforme.

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2015-05-05
Last Posted Date
2021-04-21
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
9
Registration Number
NCT02433392
Locations
🇬🇧

Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction

First Posted Date
2015-05-05
Last Posted Date
2021-08-17
Lead Sponsor
Boston Scientific Corporation
Target Recruit Count
1173
Registration Number
NCT02433379
Locations
🇺🇸

Harbor UCLA Medical Center, Torrance, California, United States

🇺🇸

William Beaumont Hospital, Royal Oak, Michigan, United States

🇺🇸

Cox Health, Springfield, Missouri, United States

and more 106 locations
© Copyright 2024. All Rights Reserved by MedPath